nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0367	0.0485	CbGbCtD
Alprazolam—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0367	0.0485	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0317	0.0419	CbGbCtD
Alprazolam—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0317	0.0419	CbGbCtD
Alprazolam—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0307	0.0407	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0307	0.0407	CbGbCtD
Alprazolam—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0304	0.0403	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0278	0.0368	CbGbCtD
Alprazolam—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0278	0.0368	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0278	0.0368	CbGbCtD
Alprazolam—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0278	0.0368	CbGbCtD
Alprazolam—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0275	0.0364	CbGbCtD
Alprazolam—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0275	0.0364	CbGbCtD
Alprazolam—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0238	0.0314	CbGbCtD
Alprazolam—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0231	0.0305	CbGbCtD
Alprazolam—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0217	0.0287	CbGbCtD
Alprazolam—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0209	0.0276	CbGbCtD
Alprazolam—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0209	0.0276	CbGbCtD
Alprazolam—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0204	0.027	CbGbCtD
Alprazolam—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0204	0.027	CbGbCtD
Alprazolam—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0185	0.0244	CbGbCtD
Alprazolam—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0185	0.0244	CbGbCtD
Alprazolam—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0159	0.0211	CbGbCtD
Alprazolam—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0155	0.0205	CbGbCtD
Alprazolam—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.014	0.0185	CbGbCtD
Alprazolam—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.014	0.0185	CbGbCtD
Alprazolam—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0134	0.0177	CbGbCtD
Alprazolam—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0126	0.0167	CbGbCtD
Alprazolam—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0119	0.0157	CbGbCtD
Alprazolam—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0119	0.0157	CbGbCtD
Alprazolam—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0107	0.0142	CbGbCtD
Alprazolam—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0107	0.0142	CbGbCtD
Alprazolam—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00926	0.0123	CbGbCtD
Alprazolam—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00899	0.0119	CbGbCtD
Alprazolam—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00813	0.0108	CbGbCtD
Alprazolam—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00813	0.0108	CbGbCtD
Alprazolam—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0078	0.0103	CbGbCtD
Alprazolam—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000725	0.0467	CbGeAlD
Alprazolam—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000714	0.046	CbGeAlD
Alprazolam—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000544	0.035	CbGeAlD
Alprazolam—GABRA5—nervous system—acquired immunodeficiency syndrome	0.000543	0.0349	CbGeAlD
Alprazolam—GABRA5—central nervous system—acquired immunodeficiency syndrome	0.000522	0.0336	CbGeAlD
Alprazolam—GABRA3—nervous system—acquired immunodeficiency syndrome	0.000505	0.0325	CbGeAlD
Alprazolam—GABRG2—spinal cord—acquired immunodeficiency syndrome	0.000489	0.0315	CbGeAlD
Alprazolam—GABRB2—spinal cord—acquired immunodeficiency syndrome	0.000489	0.0315	CbGeAlD
Alprazolam—GABRA3—central nervous system—acquired immunodeficiency syndrome	0.000486	0.0313	CbGeAlD
Alprazolam—GABRB2—lung—acquired immunodeficiency syndrome	0.000445	0.0286	CbGeAlD
Alprazolam—GABRA1—spinal cord—acquired immunodeficiency syndrome	0.000431	0.0278	CbGeAlD
Alprazolam—GABRA2—vagina—acquired immunodeficiency syndrome	0.00043	0.0277	CbGeAlD
Alprazolam—GABRA5—brain—acquired immunodeficiency syndrome	0.000415	0.0267	CbGeAlD
Alprazolam—GABRB2—nervous system—acquired immunodeficiency syndrome	0.000412	0.0265	CbGeAlD
Alprazolam—GABRG2—nervous system—acquired immunodeficiency syndrome	0.000412	0.0265	CbGeAlD
Alprazolam—GABRB2—central nervous system—acquired immunodeficiency syndrome	0.000396	0.0255	CbGeAlD
Alprazolam—GABRG2—central nervous system—acquired immunodeficiency syndrome	0.000396	0.0255	CbGeAlD
Alprazolam—GABRA3—brain—acquired immunodeficiency syndrome	0.000386	0.0249	CbGeAlD
Alprazolam—GABRA2—nervous system—acquired immunodeficiency syndrome	0.000376	0.0242	CbGeAlD
Alprazolam—GABRB3—spinal cord—acquired immunodeficiency syndrome	0.000375	0.0242	CbGeAlD
Alprazolam—GABRA1—nervous system—acquired immunodeficiency syndrome	0.000364	0.0234	CbGeAlD
Alprazolam—GABRA2—central nervous system—acquired immunodeficiency syndrome	0.000362	0.0233	CbGeAlD
Alprazolam—GABRA1—central nervous system—acquired immunodeficiency syndrome	0.00035	0.0225	CbGeAlD
Alprazolam—GABRB3—lung—acquired immunodeficiency syndrome	0.000341	0.022	CbGeAlD
Alprazolam—GABRB3—nervous system—acquired immunodeficiency syndrome	0.000316	0.0204	CbGeAlD
Alprazolam—GABRB2—brain—acquired immunodeficiency syndrome	0.000315	0.0203	CbGeAlD
Alprazolam—GABRG2—brain—acquired immunodeficiency syndrome	0.000315	0.0203	CbGeAlD
Alprazolam—GABRB3—central nervous system—acquired immunodeficiency syndrome	0.000304	0.0196	CbGeAlD
Alprazolam—GABRA2—brain—acquired immunodeficiency syndrome	0.000288	0.0185	CbGeAlD
Alprazolam—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000279	0.018	CbGeAlD
Alprazolam—GABRA1—brain—acquired immunodeficiency syndrome	0.000278	0.0179	CbGeAlD
Alprazolam—GABRA2—lymph node—acquired immunodeficiency syndrome	0.000278	0.0179	CbGeAlD
Alprazolam—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000274	0.0177	CbGeAlD
Alprazolam—CYP3A5—blood—acquired immunodeficiency syndrome	0.000266	0.0171	CbGeAlD
Alprazolam—CYP2C9—blood—acquired immunodeficiency syndrome	0.000261	0.0168	CbGeAlD
Alprazolam—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000246	0.0159	CbGeAlD
Alprazolam—GABRB3—brain—acquired immunodeficiency syndrome	0.000242	0.0156	CbGeAlD
Alprazolam—CYP3A5—lung—acquired immunodeficiency syndrome	0.000233	0.015	CbGeAlD
Alprazolam—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000209	0.0135	CbGeAlD
Alprazolam—CYP3A4—blood—acquired immunodeficiency syndrome	0.000199	0.0128	CbGeAlD
Alprazolam—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000162	0.0104	CbGeAlD
Alprazolam—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000156	0.01	CbGeAlD
Alprazolam—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000153	0.000672	CcSEcCtD
Alprazolam—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000671	CcSEcCtD
Alprazolam—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000153	0.000671	CcSEcCtD
Alprazolam—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000153	0.00067	CcSEcCtD
Alprazolam—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000153	0.000668	CcSEcCtD
Alprazolam—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000153	0.000668	CcSEcCtD
Alprazolam—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000667	CcSEcCtD
Alprazolam—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000666	CcSEcCtD
Alprazolam—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000666	CcSEcCtD
Alprazolam—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000666	CcSEcCtD
Alprazolam—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000666	CcSEcCtD
Alprazolam—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000664	CcSEcCtD
Alprazolam—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000664	CcSEcCtD
Alprazolam—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000662	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000661	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000659	CcSEcCtD
Alprazolam—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00015	0.000659	CcSEcCtD
Alprazolam—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000658	CcSEcCtD
Alprazolam—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00015	0.000658	CcSEcCtD
Alprazolam—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000658	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.000657	CcSEcCtD
Alprazolam—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000656	CcSEcCtD
Alprazolam—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000149	0.000653	CcSEcCtD
Alprazolam—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000149	0.000653	CcSEcCtD
Alprazolam—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000149	0.000652	CcSEcCtD
Alprazolam—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000652	CcSEcCtD
Alprazolam—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000651	CcSEcCtD
Alprazolam—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000148	0.000649	CcSEcCtD
Alprazolam—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000148	0.000649	CcSEcCtD
Alprazolam—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000148	0.000648	CcSEcCtD
Alprazolam—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000648	CcSEcCtD
Alprazolam—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000648	CcSEcCtD
Alprazolam—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000148	0.000646	CcSEcCtD
Alprazolam—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000148	0.000646	CcSEcCtD
Alprazolam—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000645	CcSEcCtD
Alprazolam—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000645	CcSEcCtD
Alprazolam—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000644	CcSEcCtD
Alprazolam—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000644	CcSEcCtD
Alprazolam—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.000643	CcSEcCtD
Alprazolam—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.000641	CcSEcCtD
Alprazolam—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000641	CcSEcCtD
Alprazolam—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000641	CcSEcCtD
Alprazolam—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000641	CcSEcCtD
Alprazolam—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000639	CcSEcCtD
Alprazolam—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000638	CcSEcCtD
Alprazolam—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000146	0.000637	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000637	CcSEcCtD
Alprazolam—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000635	CcSEcCtD
Alprazolam—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000633	CcSEcCtD
Alprazolam—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000631	CcSEcCtD
Alprazolam—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000144	0.000629	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000629	CcSEcCtD
Alprazolam—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000628	CcSEcCtD
Alprazolam—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000627	CcSEcCtD
Alprazolam—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000627	CcSEcCtD
Alprazolam—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000143	0.000627	CcSEcCtD
Alprazolam—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000626	CcSEcCtD
Alprazolam—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000143	0.000625	CcSEcCtD
Alprazolam—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000625	CcSEcCtD
Alprazolam—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.000624	CcSEcCtD
Alprazolam—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000623	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000623	CcSEcCtD
Alprazolam—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000622	CcSEcCtD
Alprazolam—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000142	0.000622	CcSEcCtD
Alprazolam—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000622	CcSEcCtD
Alprazolam—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.00062	CcSEcCtD
Alprazolam—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.00062	CcSEcCtD
Alprazolam—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.00062	CcSEcCtD
Alprazolam—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000617	CcSEcCtD
Alprazolam—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.000617	CcSEcCtD
Alprazolam—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000141	0.000617	CcSEcCtD
Alprazolam—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000141	0.000616	CcSEcCtD
Alprazolam—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000616	CcSEcCtD
Alprazolam—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000141	0.000615	CcSEcCtD
Alprazolam—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000615	CcSEcCtD
Alprazolam—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000614	CcSEcCtD
Alprazolam—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00014	0.000613	CcSEcCtD
Alprazolam—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000612	CcSEcCtD
Alprazolam—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000612	CcSEcCtD
Alprazolam—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000612	CcSEcCtD
Alprazolam—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.00061	CcSEcCtD
Alprazolam—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000609	CcSEcCtD
Alprazolam—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000609	CcSEcCtD
Alprazolam—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000608	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000607	CcSEcCtD
Alprazolam—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000139	0.000607	CcSEcCtD
Alprazolam—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000605	CcSEcCtD
Alprazolam—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000604	CcSEcCtD
Alprazolam—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000138	0.000604	CcSEcCtD
Alprazolam—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000138	0.000604	CcSEcCtD
Alprazolam—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000603	CcSEcCtD
Alprazolam—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.000603	CcSEcCtD
Alprazolam—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000137	0.000601	CcSEcCtD
Alprazolam—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.0006	CcSEcCtD
Alprazolam—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000598	CcSEcCtD
Alprazolam—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000137	0.000598	CcSEcCtD
Alprazolam—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000136	0.000597	CcSEcCtD
Alprazolam—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000597	CcSEcCtD
Alprazolam—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000597	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000596	CcSEcCtD
Alprazolam—Rash—Stavudine—acquired immunodeficiency syndrome	0.000136	0.000596	CcSEcCtD
Alprazolam—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000595	CcSEcCtD
Alprazolam—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000136	0.000595	CcSEcCtD
Alprazolam—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000595	CcSEcCtD
Alprazolam—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000594	CcSEcCtD
Alprazolam—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000136	0.000594	CcSEcCtD
Alprazolam—Headache—Stavudine—acquired immunodeficiency syndrome	0.000135	0.000592	CcSEcCtD
Alprazolam—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000135	0.000592	CcSEcCtD
Alprazolam—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000591	CcSEcCtD
Alprazolam—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.00059	CcSEcCtD
Alprazolam—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.00059	CcSEcCtD
Alprazolam—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000135	0.000589	CcSEcCtD
Alprazolam—Rash—Abacavir—acquired immunodeficiency syndrome	0.000134	0.000587	CcSEcCtD
Alprazolam—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000134	0.000586	CcSEcCtD
Alprazolam—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000586	CcSEcCtD
Alprazolam—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000586	CcSEcCtD
Alprazolam—Headache—Abacavir—acquired immunodeficiency syndrome	0.000133	0.000583	CcSEcCtD
Alprazolam—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000582	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000582	CcSEcCtD
Alprazolam—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000133	0.000581	CcSEcCtD
Alprazolam—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.000581	CcSEcCtD
Alprazolam—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000577	CcSEcCtD
Alprazolam—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000577	CcSEcCtD
Alprazolam—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000575	CcSEcCtD
Alprazolam—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000574	CcSEcCtD
Alprazolam—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000573	CcSEcCtD
Alprazolam—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.000573	CcSEcCtD
Alprazolam—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00013	0.00057	CcSEcCtD
Alprazolam—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00013	0.00057	CcSEcCtD
Alprazolam—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000569	CcSEcCtD
Alprazolam—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000569	CcSEcCtD
Alprazolam—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.000569	CcSEcCtD
Alprazolam—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000568	CcSEcCtD
Alprazolam—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000567	CcSEcCtD
Alprazolam—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000565	CcSEcCtD
Alprazolam—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000129	0.000563	CcSEcCtD
Alprazolam—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000563	CcSEcCtD
Alprazolam—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000562	CcSEcCtD
Alprazolam—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000128	0.000562	CcSEcCtD
Alprazolam—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000128	0.000561	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.00056	CcSEcCtD
Alprazolam—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000559	CcSEcCtD
Alprazolam—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000556	CcSEcCtD
Alprazolam—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000555	CcSEcCtD
Alprazolam—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000126	0.000553	CcSEcCtD
Alprazolam—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000552	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000551	CcSEcCtD
Alprazolam—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.00055	CcSEcCtD
Alprazolam—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000548	CcSEcCtD
Alprazolam—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000125	0.000548	CcSEcCtD
Alprazolam—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000548	CcSEcCtD
Alprazolam—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000548	CcSEcCtD
Alprazolam—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000546	CcSEcCtD
Alprazolam—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000546	CcSEcCtD
Alprazolam—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000546	CcSEcCtD
Alprazolam—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000546	CcSEcCtD
Alprazolam—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000124	0.000543	CcSEcCtD
Alprazolam—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000541	CcSEcCtD
Alprazolam—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000123	0.00054	CcSEcCtD
Alprazolam—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000534	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000534	CcSEcCtD
Alprazolam—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000532	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000531	CcSEcCtD
Alprazolam—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.00053	CcSEcCtD
Alprazolam—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.00053	CcSEcCtD
Alprazolam—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000526	CcSEcCtD
Alprazolam—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000526	CcSEcCtD
Alprazolam—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000525	CcSEcCtD
Alprazolam—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000523	CcSEcCtD
Alprazolam—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000119	0.000523	CcSEcCtD
Alprazolam—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000522	CcSEcCtD
Alprazolam—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000522	CcSEcCtD
Alprazolam—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000521	CcSEcCtD
Alprazolam—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000518	CcSEcCtD
Alprazolam—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000518	CcSEcCtD
Alprazolam—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000517	CcSEcCtD
Alprazolam—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000516	CcSEcCtD
Alprazolam—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000514	CcSEcCtD
Alprazolam—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000511	CcSEcCtD
Alprazolam—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.00051	CcSEcCtD
Alprazolam—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000509	CcSEcCtD
Alprazolam—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000507	CcSEcCtD
Alprazolam—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000506	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000506	CcSEcCtD
Alprazolam—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000505	CcSEcCtD
Alprazolam—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000115	0.000505	CcSEcCtD
Alprazolam—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000505	CcSEcCtD
Alprazolam—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000505	CcSEcCtD
Alprazolam—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000502	CcSEcCtD
Alprazolam—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000501	CcSEcCtD
Alprazolam—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000495	CcSEcCtD
Alprazolam—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000494	CcSEcCtD
Alprazolam—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000488	CcSEcCtD
Alprazolam—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000488	CcSEcCtD
Alprazolam—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000111	0.000488	CcSEcCtD
Alprazolam—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000486	CcSEcCtD
Alprazolam—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000486	CcSEcCtD
Alprazolam—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000486	CcSEcCtD
Alprazolam—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000483	CcSEcCtD
Alprazolam—Rash—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000482	CcSEcCtD
Alprazolam—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000481	CcSEcCtD
Alprazolam—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000479	CcSEcCtD
Alprazolam—Headache—Indinavir—acquired immunodeficiency syndrome	0.000109	0.000478	CcSEcCtD
Alprazolam—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000477	CcSEcCtD
Alprazolam—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000472	CcSEcCtD
Alprazolam—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.00047	CcSEcCtD
Alprazolam—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000466	CcSEcCtD
Alprazolam—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000463	CcSEcCtD
Alprazolam—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000463	CcSEcCtD
Alprazolam—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000459	CcSEcCtD
Alprazolam—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000458	CcSEcCtD
Alprazolam—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000457	CcSEcCtD
Alprazolam—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000455	CcSEcCtD
Alprazolam—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000455	CcSEcCtD
Alprazolam—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000454	CcSEcCtD
Alprazolam—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000453	CcSEcCtD
Alprazolam—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000452	CcSEcCtD
Alprazolam—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000452	CcSEcCtD
Alprazolam—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000441	CcSEcCtD
Alprazolam—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000439	CcSEcCtD
Alprazolam—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	9.98e-05	0.000437	CcSEcCtD
Alprazolam—Rash—Delavirdine—acquired immunodeficiency syndrome	9.95e-05	0.000435	CcSEcCtD
Alprazolam—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	9.94e-05	0.000435	CcSEcCtD
Alprazolam—Pruritus—Saquinavir—acquired immunodeficiency syndrome	9.94e-05	0.000435	CcSEcCtD
Alprazolam—Headache—Delavirdine—acquired immunodeficiency syndrome	9.88e-05	0.000433	CcSEcCtD
Alprazolam—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	9.87e-05	0.000432	CcSEcCtD
Alprazolam—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.8e-05	0.000429	CcSEcCtD
Alprazolam—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9.65e-05	0.000422	CcSEcCtD
Alprazolam—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.61e-05	0.000421	CcSEcCtD
Alprazolam—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	9.61e-05	0.00042	CcSEcCtD
Alprazolam—Pruritus—Lamivudine—acquired immunodeficiency syndrome	9.48e-05	0.000415	CcSEcCtD
Alprazolam—Nausea—Delavirdine—acquired immunodeficiency syndrome	9.37e-05	0.00041	CcSEcCtD
Alprazolam—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.29e-05	0.000406	CcSEcCtD
Alprazolam—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.28e-05	0.000406	CcSEcCtD
Alprazolam—Rash—Ritonavir—acquired immunodeficiency syndrome	9.2e-05	0.000403	CcSEcCtD
Alprazolam—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.19e-05	0.000402	CcSEcCtD
Alprazolam—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.17e-05	0.000401	CcSEcCtD
Alprazolam—Headache—Ritonavir—acquired immunodeficiency syndrome	9.14e-05	0.0004	CcSEcCtD
Alprazolam—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.93e-05	0.000391	CcSEcCtD
Alprazolam—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.86e-05	0.000388	CcSEcCtD
Alprazolam—Rash—Saquinavir—acquired immunodeficiency syndrome	8.85e-05	0.000387	CcSEcCtD
Alprazolam—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.85e-05	0.000387	CcSEcCtD
Alprazolam—Headache—Saquinavir—acquired immunodeficiency syndrome	8.8e-05	0.000385	CcSEcCtD
Alprazolam—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.67e-05	0.000379	CcSEcCtD
Alprazolam—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.52e-05	0.000373	CcSEcCtD
Alprazolam—Rash—Lamivudine—acquired immunodeficiency syndrome	8.45e-05	0.00037	CcSEcCtD
Alprazolam—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.44e-05	0.000369	CcSEcCtD
Alprazolam—Headache—Lamivudine—acquired immunodeficiency syndrome	8.39e-05	0.000367	CcSEcCtD
Alprazolam—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.34e-05	0.000365	CcSEcCtD
Alprazolam—Nausea—Lamivudine—acquired immunodeficiency syndrome	7.96e-05	0.000348	CcSEcCtD
